ClinicalTrials.Veeva

Menu

Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (ELDERGRAF)

A

Assistance Publique - Hôpitaux de Paris

Status

Active, not recruiting

Conditions

Stem Cell Transplant

Treatments

Other: Comprehensive geriatric assessment (CGA)

Study type

Observational

Funder types

Other

Identifiers

NCT04375579
APHP200084

Details and patient eligibility

About

Patients older than 60 years are more and more transplanted. Comprehensive geriatric assessment (CGA) have been developed and are currently used in patients with cancer, it has been correlated with the prognosis. There is still few data in transplanted patients and the aim of this study is to assess these patients before and after transplantation in order to monitor their general health and quality of life (QOF) and correlate them to the prognostic.

Enrollment

205 patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 60 years or more at time of transplantation
  • Patient receiving a hematopoietic stem cell allograft for myeloid hemopathy (myeloid acute leukemia, myelodysplastic syndrome, Myeloproliferative neoplasm) or for an Acute lymphoblastic leukemia
  • No opposition to participate

Exclusion criteria

  • Patient opposed to the protocol
  • Vulnerable patients protected by curatorship or administrative supervision
  • Patients not covered by a social security scheme

Trial contacts and locations

18

Loading...

Central trial contact

Matthieu Resche-Rigon; Marie Robin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems